Innovation Ecosystem

Breakthroughs in life sciences rarely happen in isolation. Bringing a new therapy or medical device from concept to reality requires collaboration across disciplines, industries and borders.
Beyond physical space, Biosparc is committed to building a globally connected innovation ecosystem, drawing on the international networks of our shareholders to bring together the expertise, resources and partnerships needed to accelerate innovation.

Scroll More

Our Innovation Focus

We seek out and support innovation worldwide, with a focus on new modalities, next-generation therapeutics and emerging technologies, as well as AI-enabled solutions advancing healthcare and life sciences.

Next-Generation Biotech

Next-Generation Biotech

Advancing new modalities, novel therapeutic approaches and emerging biotechnologies with the potential to address unmet medical needs.

Advanced Medical Devices & Life Science Tools

Advanced Medical Devices & Life Science Tools

Supporting innovative medical devices, advanced equipment and life science tools with strong real-world applications and commercialization potential.

AI-Enabled Healthcare

AI-Enabled Healthcare

Exploring AI-enabled solutions across drug discovery, diagnostics, clinical decision-making and precision medicine.

An Ecosystem Built Around Innovators

An ecosystem is not merely a directory of resources. It takes shape when those resources are close enough, and in contact often enough, to act on one another. BioSparc builds from within the industry — bringing research, clinic, manufacturing, and capital into a shared orbit, where proximity drives collaboration and collaboration accelerates innovation.

Research Institutes

Where discovery begins

Biosparc partners with leading universities and research institutes to carry fundamental science toward industrial application. Through joint labs, technology transfer programs, and shared research platforms, breakthroughs move seamlessly from bench to venture.

Clinical Network

From bench to bedside

Access to top-tier hospitals, clinical trial centers, and globally impactful medical journals accelerates clinical validation. Biosparc connects innovators with clinical partners and trial infrastructure, turning a promising result into proven evidence.

Industry & Supply Chain Partners

Turning scientific ideas into clinical products

A curated network of trusted CROs, CDMOs, component suppliers, and manufacturing partners means companies never build alone. From preclinical services to GMP production and quality systems, Biosparc coordinates the supply chain so innovators can focus on what they do best.

Innovators

From breakthrough ideas to global impact

Biosparc brings together innovative biotech, medtech, and life sciences companies at different stages of development. By connecting them with research institutions, clinical networks, industry partners, capital, and global resources, Biosparc facilitates collaboration and helps accelerate technology development, commercialization, and international expansion.

Investors & BD Partners

Capital across the full cycle

From seed funding to growth capital, licensing deals to cross-border partnerships — Biosparc is actively building an investor network that spans the full company lifecycle. Resident companies gain direct access to venture funds, strategic corporates, and BD professionals who understand both science and markets.

AI Infrastructure AI

Intelligence built into the ecosystem

From AI-driven drug discovery platforms to computational biology tools and smart lab operations, BioSparc embeds AI capability at every layer. Shared compute resources, data platforms, and AI expertise help every resident company work faster and smarter.

Bridging China and Global Innovation

Building on the China–Singapore Innovation Corridor, Biosparc bridges global innovation with China's life sciences ecosystem, while connecting Chinese innovators with international partners and market opportunities.

China–Singapore Innovation Corridor

· Cross-Border Technology Translation: Combine Singapore's research and clinical capabilities with China's industrial strengths to accelerate the translation of scientific discoveries into practical applications.
· Southeast Asia Market Access: Facilitate the expansion of innovative Chinese therapies and medical technologies into Singapore and Southeast Asian markets.

Global Innovation Networks

· China Entry & Global Growth: Enable international companies to navigate China's business and regulatory environment, establish operations efficiently and leverage local resources for global growth.- Global Connections: Connect Chinese innovators with global investors, industry leaders and strategic partners to facilitate international collaboration and accelerate global expansion.
· Global Connections: Connect Chinese innovators with global investors, industry leaders and strategic partners to facilitate international collaboration and accelerate global expansion.

Through these interconnected networks, Biosparc brings Chinese and global innovators closer together, creating new opportunities for collaboration, innovation and growth.

Ecosystem Partners

Bringing together research institutions, healthcare organizations, investors, professional service providers, and industry partners to support innovation and growth across the life sciences ecosystem.

Innovate, and Grow with Biosparc

Explore the opportunities at Biosparc and take your innovation further.

Back

Tigermed

Since its inception in 2004, Tigermed (300347.SZ / 3347.HK) has been a trusted clinical research organization that provides full-service for the global biopharmaceutical and medical device industries. We are devoted to serving our customers in their clinical development journey efficiently and cost-effectively. For twenty years, we have been accelerating the launch of innovative healthcare products with our quality, solutions, teams, experience, and expertise, to advance human health.

Visit Website